Related Experiment Video
Updated: May 2, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
42.1K
Mephedrone inhalation causes pneumomediastinum
Ruth Graham1, Nia Bowen, Joy Singh
1Department of General Surgery, West Wales General Hospital, Carmarthen, UK.
BMJ Case Reports
|March 12, 2014
Summary
Recreational drug use, specifically mephedrone inhalation, can lead to serious chest conditions like pneumomediastinum and subcutaneous emphysema. This case highlights the importance of considering drug-induced injury in young patients presenting with these symptoms.
Area of Science:
- Medicine
- Toxicology
- Radiology
Background:
- Subcutaneous emphysema and pneumomediastinum are rare complications.
- Mephedrone, a synthetic stimulant, has been associated with various adverse health effects.
Observation:
- A 17-year-old male presented with neck swelling, pain, and dysphonia.
- Physical examination revealed subcutaneous emphysema in the supraclavicular and chest wall regions.
- Imaging confirmed pneumomediastinum and subcutaneous emphysema.
Findings:
- The patient reported recent mephedrone inhalation without any history of trauma.
- Conservative management, including prophylactic antibiotics and dietary adjustments, was successful.
- Symptoms including dysphonia and emphysema resolved within days.
Implications:
- This case suggests a potential link between mephedrone inhalation and the development of pneumomediastinum and subcutaneous emphysema.
- Clinicians should consider recreational drug use in the differential diagnosis for patients presenting with these radiological findings.
- Further research is warranted to understand the pathophysiology and long-term consequences of drug-induced pneumomediastinum.
Related Concept Videos
01:27Pneumothorax-II
1.7K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.7K
01:23Inhaled Medications
1.1K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
01:26Pneumothorax-I
2.2K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
2.2K
01:29Pneumonia I: Introduction
24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
01:30Pneumonia I: Introduction
1.5K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
01:08Pneumothorax II: Pathophysiology
55
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance...
55